Uphar Medical Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.60 M
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.95 M
- Revenue Growth -14.34%
- Profit Growth -20.70%
- Ebitda -20.84%
- Net Worth 8.51%
- Total Assets 8.83%
About Uphar Medical Research Centre
Uphar Medical Research Centre Private Limited (UMRCPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 October 2005 and has a history of 19 years and four months. Its registered office is in Saran, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹4.95 M.
Rajib Singh and Vijaya Singh serve as directors at the Company.
Company Details
- Location
Saran, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110BR2005PTC011672
- Company No.
011672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Uphar Medical Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Singh  | Managing Director | 04-Oct-2005 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Singh | Director | 04-Oct-2005 | Current |
Financial Performance of Uphar Medical Research Centre.
Uphar Medical Research Centre Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.34% decrease. The company also saw a substantial fall in profitability, with a 20.7% decrease in profit. The company's net worth moved up by a moderate rise of 8.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uphar Medical Research Centre?
In 2020, Uphar Medical Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.95 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.40 Cr
- Bank Of Baroda : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2013 | State Bank Of India | ₹4.00 M | Open |
| 24 Jan 2013 | Bank Of Baroda | ₹0.95 M | Open |
How Many Employees Work at Uphar Medical Research Centre?
Unlock and access historical data on people associated with Uphar Medical Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uphar Medical Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uphar Medical Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.